47 reports

In May 2011, Radius Health, Inc. and ##M Drug Delivery Systems, announced an exclusive partnership agreement for development and commercialization of BA##-transdermal (TD).

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • MONOCLONAL ANTIBODY TO INHIBIT TGFB1 FOR ONCOLOGY - DRUG PROFILE

Transdermal Sirna Delivery to Improve Wound Healing".

  • Immunotherapy
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Sirnaomics, Inc.

Transdermal Sirna Delivery to Improve Wound Healing".

  • Immunotherapy
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Sirnaomics, Inc.

According to an FDA report of the product quality of transdermal drug delivery systems, adhesion was the most widely reported quality defect of transdermal patches.

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • United States
  • Sorrento Therapeutics, Inc.

The transdermal formulation of BA-## is based on microstructured transdermal system technology.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Company
  • Product Initiative

Neupro is the only non-ergot DA in the current market that uses a transdermal delivery system.

  • Monoclonal Antibody
  • Therapy
  • Company
  • Company Financials
  • Forecast

Radius also is developing abaloparatide patch based on ##M' s patented Microstructured Transdermal System technology for potential use as a treatment for postmenopausal women with osteoporosis.

  • Clinical Trial
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Therapy
  • Eli Lilly & Co.

Radius also is developing abaloparatide patch based on ##M' s patented Microstructured Transdermal System technology for potential use as a treatment for postmenopausal women with osteoporosis.

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • World

IT IS DEVELOPED BASED ON TRANSDERMAL DRUG DELIVERY TECHNOLOGY.

  • Chronic Pain
  • Monoclonal Antibody
  • Neurological Disorder
  • Pharmaceutical
  • Can-Fite BioPharma Ltd.

IT IS AN INCREMENTALLY MODIFIED DRUG ADMINISTERED BY TRANSDERMAL ROUTE.

  • Dementia
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative

AND ##M DRUG DELIVERY SYSTEMS, ANNOUNCED AN EXCLUSIVE PARTNERSHIP AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF BA##-TRANSDERMAL (TD).

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • United States
  • Product Initiative
  • Amgen Inc.

Aptahem reports that the delivery of its drug product will be delayed.

  • Blood Disease
  • Cell Therapy
  • Monoclonal Antibody
  • Therapy
  • Bristol-Myers Squibb Company

Hoffmann-La Roche Ltd Merck & Co Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## Eli Lilly and Co ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## GlaxoSmithKline Plc DSM Biologics Holdings Inc ## ## ## ## ## ##

  • Clinical Trial
  • Endocrine Disease
  • Monoclonal Antibody
  • World
  • Amgen Inc.

The company also provides transdermal drug delivery systems that enable drug delivery as a form of transdermal patch.

  • Asthma
  • Monoclonal Antibody
  • United States
  • Company
  • AstraZeneca PLC

IT IS DEVELOPED BASED ON TRANSDERMAL DRUG DELIVERY TECHNOLOGY.

  • Chronic Pain
  • Monoclonal Antibody
  • Neurological Disorder
  • Pharmaceutical
  • Can-Fite BioPharma Ltd.

It utilizes Topicon Transdermal Delivery technology, a needle-free transdermal drug delivery technology which eliminates the use of needle injection for the delivery of life-saving drugs.

  • Antibiotic Resistance
  • Infectious Disease
  • Monoclonal Antibody
  • World
  • GlaxoSmithKline plc

THE DRUG CANDIDATE IS DEVELOPED BASED ON SELF-ASSEMBLING PEPTIDES PLATFORM (ESAP) AND NANOPARTICLE BASED DELIVERY SYSTEM.

  • Blood Disease
  • Cell Therapy
  • Monoclonal Antibody
  • Therapy
  • Bristol-Myers Squibb Company

It provides design and delivery of therapeutic agents.

  • Dementia
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Eisai Co., Ltd.

It utilizes Topicon Transdermal Delivery technology, a needle-free transdermal drug delivery technology which eliminates the use of needle injection for the delivery of life-saving drugs.

  • Cell Therapy
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative

The company develops novel controlled-release delivery system.

  • Dermatological Condition
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative

It offers products in the form of creams and gels, tablets, orodispersible films, transdermal patches, implants and inhalers.

  • Autoimmune Disease
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative

It is administered transdermally as a gel formulation.

  • Dermatological Condition
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • ELMYELIN - DRUG PROFILE

THE DRUG CANDIDATE IS ADMINISTERED THROUGH TRANSDERMAL ROUTE.

  • Monoclonal Antibody
  • Neurological Disorder
  • Pathology
  • Therapy
  • Anavex Life Sciences Corp.

AND ##M DRUG DELIVERY SYSTEMS, ANNOUNCED AN EXCLUSIVE PARTNERSHIP AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF BA##-TRANSDERMAL (TD).

  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Oncology
  • Company
  • Product Initiative

It offers products in the form of creams and gels, tablets, orodispersible films, transdermal patches, implants and inhalers.

  • Autoimmune Disease
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative

IT IS ADMINISTERED THROUGH TOPICAL, ORAL AND TRANSDERMAL ROUTES.

  • Dermatological Condition
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative

The company also provides transdermal drug delivery systems that enable drug delivery as a form of transdermal patch.

  • Immunotherapy
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • AstraZeneca PLC
  • ELMYELIN - DRUG PROFILE

THE DRUG CANDIDATE IS ADMINISTERED THROUGH TRANSDERMAL ROUTE.

  • Cell Therapy
  • Monoclonal Antibody
  • Neurological Disorder
  • Pathology
  • Anavex Life Sciences Corp.

It utilizes Topicon Transdermal Delivery technology, a needle-free transdermal drug delivery technology which eliminates the use of needle injection for the delivery of life-saving drugs.

  • Monoclonal Antibody
  • World
  • Company
  • Company Operations
  • Product Initiative

Radius also is developing abaloparatide-transdermal (abaloparatide-TD) based on ##M' s patented Microstructured Transdermal System technology for potential use as a short wear-time transdermal patch.

  • Clinical Trial
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • World